July 15, 2020
Greetings CURE community,
As the COVID-19 pandemic continues to dominate our lives, CURE is focusing on long-term impacts for epilepsy research. Current CURE Grantees are finding ways to continue their studies, but with severe restrictions on laboratory access, many researchers have had to limit or stop their work. Consequently, research projects will be delayed or may even be terminated altogether. Reduced funding from institutions and government agencies also threaten the success of projects. Scientists must now not only pay their teams’ salary and manage day-to-day lab costs, but also cover unexpected expenses related to sanitation and employee protection. CURE founder, Susan Axelrod, and I further discuss the impacts of quarantine on the research community in this statement, which we encourage you to read. The fact is that epilepsy hasn’t stopped, and neither have we. People with epilepsy and their families can’t afford for progress to be slowed or halted. Now more than ever, it is critical for CURE to continue awarding grants to dedicated scientists searching for cures. Your support enables us to fund these innovators and generate real progress. Please make your gift today to ensure a future filled with research-driven discoveries. In addition to helping us fund future research, here are other ways you can get involved or learn more about our work:
Be well, Beth Lewin Dean, CEO |
|
|
|
|
|